Paragon 28 (FNA) Competitors $10.03 +0.23 (+2.35%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends FNA vs. NVCR, NVST, NARI, IRTC, LIVN, ENOV, WRBY, CNMD, TNDM, and TMDXShould you be buying Paragon 28 stock or one of its competitors? The main competitors of Paragon 28 include NovoCure (NVCR), Envista (NVST), Inari Medical (NARI), iRhythm Technologies (IRTC), LivaNova (LIVN), Enovis (ENOV), Warby Parker (WRBY), CONMED (CNMD), Tandem Diabetes Care (TNDM), and TransMedics Group (TMDX). These companies are all part of the "medical equipment" industry. Paragon 28 vs. NovoCure Envista Inari Medical iRhythm Technologies LivaNova Enovis Warby Parker CONMED Tandem Diabetes Care TransMedics Group Paragon 28 (NYSE:FNA) and NovoCure (NASDAQ:NVCR) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, valuation, analyst recommendations, media sentiment, community ranking, dividends, risk, institutional ownership and earnings. Do analysts rate FNA or NVCR? Paragon 28 currently has a consensus price target of $15.60, suggesting a potential upside of 55.53%. NovoCure has a consensus price target of $32.67, suggesting a potential upside of 6.06%. Given Paragon 28's stronger consensus rating and higher possible upside, research analysts plainly believe Paragon 28 is more favorable than NovoCure.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Paragon 28 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 3.20NovoCure 0 Sell rating(s) 2 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.67 Which has more risk and volatility, FNA or NVCR? Paragon 28 has a beta of 1.52, meaning that its stock price is 52% more volatile than the S&P 500. Comparatively, NovoCure has a beta of 0.75, meaning that its stock price is 25% less volatile than the S&P 500. Do insiders and institutionals hold more shares of FNA or NVCR? 63.6% of Paragon 28 shares are owned by institutional investors. Comparatively, 84.6% of NovoCure shares are owned by institutional investors. 15.3% of Paragon 28 shares are owned by company insiders. Comparatively, 6.3% of NovoCure shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Which has preferable valuation and earnings, FNA or NVCR? Paragon 28 has higher earnings, but lower revenue than NovoCure. NovoCure is trading at a lower price-to-earnings ratio than Paragon 28, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioParagon 28$245.00M3.43-$57.53M-$0.74-13.55NovoCure$577.74M5.77-$207.04M-$1.40-22.00 Does the MarketBeat Community prefer FNA or NVCR? NovoCure received 442 more outperform votes than Paragon 28 when rated by MarketBeat users. However, 82.93% of users gave Paragon 28 an outperform vote while only 63.72% of users gave NovoCure an outperform vote. CompanyUnderperformOutperformParagon 28Outperform Votes3482.93% Underperform Votes717.07%NovoCureOutperform Votes47663.72% Underperform Votes27136.28% Is FNA or NVCR more profitable? Paragon 28 has a net margin of -25.31% compared to NovoCure's net margin of -25.93%. Paragon 28's return on equity of -37.90% beat NovoCure's return on equity.Company Net Margins Return on Equity Return on Assets Paragon 28-25.31% -37.90% -18.22% NovoCure -25.93%-41.48%-12.74% Does the media favor FNA or NVCR? In the previous week, Paragon 28 and Paragon 28 both had 3 articles in the media. Paragon 28's average media sentiment score of 0.45 beat NovoCure's score of 0.22 indicating that Paragon 28 is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Paragon 28 0 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral NovoCure 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryParagon 28 beats NovoCure on 12 of the 17 factors compared between the two stocks. Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Get Paragon 28 News Delivered to You Automatically Sign up to receive the latest news and ratings for FNA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FNA vs. The Competition Export to ExcelMetricParagon 28Surgical & medical instruments IndustryMedical SectorNYSE ExchangeMarket Cap$839.71M$4.34B$5.13B$19.18BDividend YieldN/A44.57%5.08%3.61%P/E Ratio-13.5525.3789.5841.30Price / Sales3.4345.951,116.1217.60Price / CashN/A43.4542.8221.28Price / Book4.897.094.775.32Net Income-$57.53M$13.64M$120.15M$989.88M7 Day Performance-3.74%-2.93%-1.92%-3.54%1 Month Performance-3.84%0.28%11.47%-3.68%1 Year Performance-20.84%40.76%30.52%12.14% Paragon 28 Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FNAParagon 283.0405 of 5 stars$10.03+2.3%$15.60+55.5%-17.7%$839.71M$245.00M-13.55343,000High Trading VolumeNVCRNovoCure2.4915 of 5 stars$32.71-2.1%$32.67-0.1%+138.4%$3.54B$577.74M-23.861,453NVSTEnvista3.9074 of 5 stars$19.55+0.4%$20.65+5.6%-21.1%$3.36B$2.50B-2.5112,800Positive NewsNARIInari Medical3.3112 of 5 stars$55.19-0.7%$58.89+6.7%-11.9%$3.23B$574.50M-41.181,300Analyst ForecastInsider TradeIRTCiRhythm Technologies3.0956 of 5 stars$89.42+3.5%$107.82+20.6%-14.3%$2.80B$492.68M-17.782,000Analyst ForecastLIVNLivaNova3.626 of 5 stars$50.42-2.1%$69.17+37.2%-4.4%$2.74B$1.24B122.622,900Analyst UpgradePositive NewsENOVEnovis2.9726 of 5 stars$46.59+1.0%$67.00+43.8%-21.5%$2.60B$2.00B-21.396,550Positive NewsWRBYWarby Parker1.5771 of 5 stars$24.31+2.9%$20.73-14.7%+99.1%$2.47B$669.77M-87.523,491Insider TradeCNMDCONMED4.6139 of 5 stars$71.67-1.2%$79.80+11.3%-36.7%$2.21B$1.29B17.234,000Positive NewsTNDMTandem Diabetes Care4.6384 of 5 stars$33.18+1.6%$53.81+62.2%+30.3%$2.18B$747.72M-16.922,400Positive NewsTMDXTransMedics Group4.0377 of 5 stars$64.50+0.4%$126.80+96.6%-20.1%$2.16B$241.62M68.36210Analyst Forecast Related Companies and Tools Related Companies NVCR Competitors NVST Competitors NARI Competitors IRTC Competitors LIVN Competitors ENOV Competitors WRBY Competitors CNMD Competitors TNDM Competitors TMDX Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:FNA) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Paragon 28, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Paragon 28 With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FNA Stock Alerts